Abstract
The introduction of genotype II African swine fever (ASF) virus (ASFV) into the Caucasus in 2007 resulted in unprecedented disease propagation via slow geographical expansion through wild boar populations, short- and long-distance human-mediated translocations, and incursions into naive wild boar and domestic pig populations. The disease is now widespread in eastern and central Europe as well as in Asia, including China. The global dimension of the current epidemic shows that all countries need to be prepared for an introduction. In its natural habitat in Africa, ASFV is maintained within an ancient cycle between soft argasid ticks and the common warthog. Once introduced to the domestic pig population, direct and indirect virus transmission occurs with or without involvement of the tick vector in the pig-tick and domestic pig epidemiological cycles respectively. In the domestic pig cycle, human activities involving pigs or pig derived products are the dominating driver of virus transmission. ASF epidemiology in the presence of wild boar and northern European climates has proved to have specific characteristics, described in the wild boar-habitat epidemiological cycle. In this cycle wild boar carcasses and the resulting contamination of the environment play key roles in virus persistence. In both the wild boar-habitat and the domestic pig epidemiological cycle, fully implemented biosecurity is the key for stopping virus transmission and controlling the disease. Positive examples from the Czech Republic and Belgium show that control and eradication of ASF from the wild boar-habitat cycle can be achieved. Both these cases, as well as the example of Sardinia, where ASFV genotype I now seem very close to eradication after more than 40 years presence, further underline the importance of involving, engaging and understanding all stakeholders in the value chains from farm and forest to fork in order to accomplish ASF control and eradication.
Highlights
A definitive diagnosis of African swine fever (ASF) is based on the results of laboratory tests, data from the farm or field and information regarding the epidemiological situation
This publication is based upon work from COST Action CA15116, ASF-STOP, supported by COST (European Cooperation in Science and Technology). www.cost.eu
This publication is based on work from ‘Understanding and combating African swine fever in Europe (ASF-STOP COST action 15116)’ supported by COST (European Cooperation in Science and Technology)
Summary
This publication is based upon work from COST Action CA15116, ASF-STOP, supported by COST (European Cooperation in Science and Technology). COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. This book is published under a cc-by license. The content of this publication and any liabilities arising from it remain the responsibility of the author. The publisher is not responsible for possible damages, which could be a result of content derived from this publication
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.